COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04588324
Brief Title: Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors

First Submitted : September 30, 2020
First Submitted that Met QC Criteria : October 8, 2020
First Posted : October 19, 2020

Last Update Submitted that Met QC Criteria : October 15, 2020
Last Update Posted : October 19, 2020